ESR1 and breast cancer: In addition, we observed a strong association with the survival of patients in the sub-group of luminal B tumors, a breast cancer molecular subtype characterized by positive ER and PGR status and a relatively unfavorable prognosis (Additional file 1: Fig. S5C).